CA2179086A1 - Derives de substitution d'imidazoles, modulant la resistance a plusieurs medicaments - Google Patents
Derives de substitution d'imidazoles, modulant la resistance a plusieurs medicamentsInfo
- Publication number
- CA2179086A1 CA2179086A1 CA002179086A CA2179086A CA2179086A1 CA 2179086 A1 CA2179086 A1 CA 2179086A1 CA 002179086 A CA002179086 A CA 002179086A CA 2179086 A CA2179086 A CA 2179086A CA 2179086 A1 CA2179086 A1 CA 2179086A1
- Authority
- CA
- Canada
- Prior art keywords
- phenyl
- alkyl
- alkylamino
- group
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002179086A CA2179086A1 (fr) | 1996-06-13 | 1996-06-13 | Derives de substitution d'imidazoles, modulant la resistance a plusieurs medicaments |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002179086A CA2179086A1 (fr) | 1996-06-13 | 1996-06-13 | Derives de substitution d'imidazoles, modulant la resistance a plusieurs medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2179086A1 true CA2179086A1 (fr) | 1997-12-14 |
Family
ID=4158406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002179086A Abandoned CA2179086A1 (fr) | 1996-06-13 | 1996-06-13 | Derives de substitution d'imidazoles, modulant la resistance a plusieurs medicaments |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2179086A1 (fr) |
-
1996
- 1996-06-13 CA CA002179086A patent/CA2179086A1/fr not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5700826A (en) | 1,2,4,5-tetra substituted imidazoles as modulators of multi-drug resistance | |
EP0999835B1 (fr) | Derives d'imidazole utilises comme modulateurs de la mdr | |
US7825261B2 (en) | Indazole compounds | |
JP4691033B2 (ja) | ジャイレース阻害剤およびその用途 | |
US5710129A (en) | Inhibitors of SH2-mediated processes | |
EP2694515B1 (fr) | Inhibiteurs de protéine kinase | |
US20120322814A1 (en) | Methods of inhibiting ire1 | |
JP2004532234A (ja) | トリアゾール由来キナーゼインヒビターおよびその使用 | |
EP2919779B1 (fr) | Composés pour la médiation d'un récepteur des cannabinoïdes | |
US20080207589A1 (en) | Cyclized derivatives as eg-5 inhibitors | |
US7902359B2 (en) | Decahydronaphthalene compounds | |
EP0812829A1 (fr) | Imidazoles substitués comme modulateurs pour suppression de la résistance à plusieurs médicaments | |
JP2022518258A (ja) | N-複素環式5員環含有カプシドタンパク質のアセンブリの阻害剤、その医薬組成物および使用 | |
US5756527A (en) | Imidazole derivatives useful as modulators of multi drug resistances | |
US7288545B2 (en) | Piperazinedione compounds | |
ZA200407709B (en) | Novel chalcone derivatives and uses thereof. | |
CN104603133A (zh) | 用于治疗癌症和免疫抑制的组合疗法 | |
CA2179086A1 (fr) | Derives de substitution d'imidazoles, modulant la resistance a plusieurs medicaments | |
US20050009054A1 (en) | Compounds having a fused, bicyclic moiety for binding to the minor groove of dsDNA | |
AU737515B2 (en) | Substituted imidazoles as modulators of multi-drug resistance | |
CA2207753A1 (fr) | Modifieurs de la resistance a plusieurs medicaments | |
JPH107660A (ja) | 多剤耐性の調節剤である置換イミダゾール類 | |
WO1999000364A1 (fr) | Composes polycarboxamido a ramifications multiples | |
EP0812830A1 (fr) | Modulateurs de la résistance à de multiples médicaments | |
AU749814B2 (en) | Modulators of multi-drug resistances |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |